Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析

◆英語タイトル:Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15769
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:80
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥56,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bristol-Myers Squibb Co (BMY) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company discovers, develops, licenses, manufactures, markets, distributes and sells medicines to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis B, hepatitis C and HIV infection) therapeutic projects. The company offers its products across the world to retail pharmacies, wholesalers, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.

Bristol-Myers Squibb Co Key Recent Developments

Mar 28,2019 Bristol-Myers Squibb and Concerto HealthAI Announce Strategic Agreement to Broaden Uses of Real-World Evidence and Accelerate Precision Oncology Innovations
Mar 20,2019 Parker Institute to share pancreatic cancer trial results, microbiome and immunotherapy research, and new CAR-T approaches at AACR 2019
Mar 19,2019 Bristol-Myers Squibb files investor presentation highlighting significant benefits of pending transaction with Celgene
Mar 01,2019 BMS faces shareholder opposition to $74bn Celgene acquisition

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bristol-Myers Squibb Co – Key Facts
Bristol-Myers Squibb Co – Key Employees
Bristol-Myers Squibb Co – Key Employee Biographies
Bristol-Myers Squibb Co – Major Products and Services
Bristol-Myers Squibb Co – History
Bristol-Myers Squibb Co – Company Statement
Bristol-Myers Squibb Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bristol-Myers Squibb Co – Business Description
Business Segment: BioPharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: United States
Performance
R&D Overview
Bristol-Myers Squibb Co – Corporate Strategy
Bristol-Myers Squibb Co – SWOT Analysis
SWOT Analysis – Overview
Bristol-Myers Squibb Co – Strengths
Bristol-Myers Squibb Co – Weaknesses
Bristol-Myers Squibb Co – Opportunities
Bristol-Myers Squibb Co – Threats
Bristol-Myers Squibb Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bristol-Myers Squibb Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 28, 2019: Bristol-Myers Squibb and Concerto HealthAI Announce Strategic Agreement to Broaden Uses of Real-World Evidence and Accelerate Precision Oncology Innovations
Mar 20, 2019: Parker Institute to share pancreatic cancer trial results, microbiome and immunotherapy research, and new CAR-T approaches at AACR 2019
Mar 19, 2019: Bristol-Myers Squibb files investor presentation highlighting significant benefits of pending transaction with Celgene
Mar 01, 2019: BMS faces shareholder opposition to $74bn Celgene acquisition
Feb 28, 2019: Bristol-Myers Squibb issues statement in response to Starboard’s letter
Feb 27, 2019: Top pharma executives testify before US Senate over high prices
Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes
Jan 24, 2019: Bristol-Myers Squibb Reports 2018 Fourth Quarter and Full Year Financial Results
Jan 24, 2019: EORTC collaborates with IDDI on ground-breaking statistical method for individualisation of therapy
Jan 15, 2019: Inovio’s dMAb PD-1 Checkpoint Inhibitors Demonstrate Higher and More Prolonged Expression Compared to Native Pembrolizumab and Nivolumab Sequences In Preclinical Studies
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bristol-Myers Squibb Co, Key Facts
Bristol-Myers Squibb Co, Key Employees
Bristol-Myers Squibb Co, Key Employee Biographies
Bristol-Myers Squibb Co, Major Products and Services
Bristol-Myers Squibb Co, History
Bristol-Myers Squibb Co, Subsidiaries
Bristol-Myers Squibb Co, Joint Venture
Bristol-Myers Squibb Co, Key Competitors
Bristol-Myers Squibb Co, Ratios based on current share price
Bristol-Myers Squibb Co, Annual Ratios
Bristol-Myers Squibb Co, Annual Ratios (Cont...1)
Bristol-Myers Squibb Co, Annual Ratios (Cont...2)
Bristol-Myers Squibb Co, Interim Ratios
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bristol-Myers Squibb Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bristol-Myers Squibb Co, Performance Chart (2014 - 2018)
Bristol-Myers Squibb Co, Ratio Charts
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bravura Solutions Limited (BVA):企業の財務・戦略的SWOT分析
    Bravura Solutions Limited (BVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Airasia Group Berhad
    Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Airasia Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hitachi Chemical Co Ltd (4217):企業の財務・戦略的SWOT分析
    Hitachi Chemical Co Ltd (4217) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hague and London Oil PLC (HNL):企業の財務・戦略的SWOT分析
    Summary Hague and London Oil PLC (HALO), formerly Wessex Exploration plc, is an oil and gas exploration company that develops resource properties. The company acquires, explores, produces, and develops oil and gas resource properties across the UK. Its projects comprise assets in the Philippines, Gu …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Lycored Ltd:企業の戦略・SWOT・財務情報
    Lycored Ltd - Strategy, SWOT and Corporate Finance Report Summary Lycored Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Olink Proteomics AB:医療機器:M&Aディール及び事業提携情報
    Summary Olink Proteomics AB (Olink) is a biotechnology company that offers products and services for human protein biomarker research. The company provides portfolio of products such as biomarkers, cardiovascular diseases panels, neurological disease panels, inflammation panels and oncology panels. …
  • OBJ Ltd (OBJ):企業の財務・戦略的SWOT分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Army and Air Force Exchange Service:企業の戦略・SWOT・財務情報
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tarveda Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti cancer medicines for advancing the treatment for solid tumors. Its pipeline prodicts …
  • Iwatani Corporation (8088):企業の財務・戦略的SWOT分析
    Iwatani Corporation (8088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ASML Holding N.V.:企業の戦略・SWOT・財務情報
    ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report Summary ASML Holding N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Magellan Health, Inc.:企業の戦略・SWOT・財務情報
    Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report Summary Magellan Health, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • PT Cikarang Listrindo (POWR):電力:M&Aディール及び事業提携情報
    Summary PT Cikarang Listrindo (Cikarang Listrindo) is a power company that generates and distributes electricity. The company offers services such as 24hours customer hotline, well trained security team, substation maintenance and calibration of kilo watt hour meters. It caters to automobile, electr …
  • Michigan Public Power Agency:企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • StealthGas Inc (GASS):企業の財務・戦略的SWOT分析
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. StealthGas transports byproducts of crude oil and natural gas inclu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆